Urology Implants and Devices Market Size, Share and Global Trend By Product Type (Endoscopes, Lithotripsy Devices, Urodynamic Systems, Urostomy Bag, Endo Vision Systems & Peripheral Instruments, Urology Implants), By Disease (Kidney Disorders, Urology Cancers, Urinary Tract Disorders, Pelvic Organ Prolapse), By End User (Hospitals, Pharmacies, Ambulatory Surgery Centers (ASC)) and Geography Forecast till 2021-2028

Urology is the study of diseases related to the male and female urinary tract, and reproductive organs. Urology devices and implants are used to treat the various urology disorders like diseases of kidney, ureter, urinary bladder, urethra, male, and female genitals, etc. The causes are urinary tract infections, pregnancy, childbirth, weakening of pelvic muscle floor, obesity, and many more. Also, factors such as western diet, lack of exercises, a sedentary lifestyle are also responsible to contribute to urological disorders. According to the American Urological Association, urinary stones are estimated to affect up to 8.8% of the U.S. population.

Also according to the National Kidney Foundation, one in five women will be diagnosed with at least one urinary tract infection (UTI) once in her lifetime. Therefore, the increase in the incidence rate of urological disorders is set to drive the growth of global urological implants and devices market during the forecast period. 

To gain extensive insights into the market, Request for Customization

Due to the development of advanced, effective, and user-friendly technologies manufacturers are into higher demand for improvising the existing solutions as well as bringing new trends for the treatment of urology disorders. Minimal use of invasive surgeries, effective, and cost-friendly devices are at higher demand and hence are responsible to drive the urology devices and implants market.

But, the high cost involved in the treatment of urology disorders is restraining the market. 

Key Players Covered

Some of the key players in Global urology devices and implants market are Boston Scientific Corporation, UroViu Corporation, Baxter, Cook, Fresenius Medical Care, Innovex Medical Co Ltd, BD (Becton Dickinson), Zhejiang Chuangxiang Medical Technology Co Ltd., and Others 

SEGMENTATION 

In the diseased segment, increasing rates of kidney disorders including kidney stones, kidney dysfunction, kidney cancer due to unhealthy lifestyle, diabetes, inadequate exercise, tobacco and alcohol use, etc. are the factors responsible to fuel the global urology implants and devices market. Urinary tract disorders are also the leading cause responsible to drive the urology implants and devices market. 

Key Insights

• Overview of cost and therapeutically effective urology implants and devices available in the market


• Recent developments in the urology implants and devices


• Reimbursement scenario in the key countries


• Key mergers and acquisitions 

Regional Analysis

Geographically the urology implants and devices market have been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the market share due to the fast adoption of technologically advanced systems for the improvement of urology healthcare, well-established healthcare facilities, and the growing prevalence of urology disorders. Europe is expected to register significant growth in urology implants and devices market due to increase in the incidence rates of kidney disorders leading to demand in urology devices, and growing investments by the manufactures to develop improvised devices will fuel the European market. 

Key Industry Developments

• In February 2019, Boston Scientific Corporation announced the launch of ADVANCE XP Male Sling System in the U.S. for male stress urinary incontinence. It includes the chevron anchoring mechanism for tissue fixation.
• In September 2018, Boston Scientific Corporation launched LITHOVUE a single-use kidney stone removal device that has helped urologist to control the ureteroscope as well as the basket at the same time which previously was a two-person job.
• In March 2018, Koninklijke Philips N.V in association with Innovative Imaging Technologies Inc. released the first telemedicine system that transmits the live ultrasound images during scans performed by a paramedic or nurse to the physician’s smartphone, tablet or computer.
• In March 2018, UroViu Corporation received FDA nod for its URO-V a single-use, semi-flexible and disposable diagnostic cystoscope for assessing the urethra and urinary bladder in women.